CONTACT|HELP

Eu2P PROVIDES UP-TO-DATE COURSES


IN PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY


THESE ARE ELIGIBLE FOR CERTIFICATE AND MASTER TRAININGS




KEY ROLES AND STAKEHOLDERS IN MEDICINES RISK COMMUNICATION: DUTIES AND CHALLENGES


MODULE OVERVIEW

Key roles and stakeholders in medicines risk communication: duties and challenges module key information
Objectives This module will address in more depth the challenges (rationale , emotional and logistical) of Risk communication that have been raised in previous modules Objectives: To consider the evolution and social impact of the concept of risk and benefit risk To explore the understanding of risk perception and uncertainty To consider challenges in healthcare providers-patients communication To know the regulatory agencies strategies to address the challenges of risk communication
Topics
  1. Historical perspective. Evolution of risk communication. Social impact of drug risk benefit communication
  2. Risk perception. Actual vs perceived and factors influencing perception. Population vs individual risk perception
  3. Concept of uncertainty. How to deal with this in risk communication
  4. Nature and importance of communication of risk of medicines from healthcare professional to patient.
  5. Regulatory agencies' strategies to address the challenges of risk communication
Keywords Evolution of risk communication, risk perception, communication of uncertainty, strategies for improving the communication of risk
Level Intermediate
Trainers' team Dr Catherine De Whalley (from AstraZeneca AB), Prof. Giampaolo Velo, Dr Anita Conforti (from Universita di Verona), Dr Paul Benkimoun [module coordinator] and Dr Marie-Pierre Barrouillet (from Université Bordeaux Segalen)
Workload 3 ECTS credits
Training mode e-learning
Language English
Eu2P training affiliation Certificate in Medicines risk communication
Master Year 2

CERTIFICATE PROGRAMME REGISTRATION

PROFILE & PREREQUISITES

  • Educational prerequisite for this module certificate programme:
    Graduate level or working experience in Health and Biological sciences

This Eu2P Certificate programme specificity also requires trainees to

  • be fluent in English
  • have Internet access and ad hoc computer equipment and be familiar with their use

KEY DATES & COURSE CALENDAR

Academic session 2013-2014
Application From April 08th, 2013 to October 27th, 2013
Selection November 04th, 2013
Registration From November 11th, 2013 to December 16th, 2013
Programme From January 06th, 2014 to April 11th, 2014
2014
JanFebMarApr
01  01  01  01 
02  02  02  02 
03  03  03  03 
04  04  04  04 
05  05  05  05 
06  06  06  06 
07  07  07  07 
08  08  08  08 
09  09  09  09 
10  10  10  10 
11  11  11  11 
12  12  12  12 
13  13  13  13 
14  14  14  14 
15  15  15  15 
16  16  16  16 
17  17  17  17 
18  18  18  18 
19  19  19  19 
20  20  20  20 
21  21  21  21 
22  22  22  22 
23  23  23  23 
24  24  24  24 
25  25  25  25 
26  26  26  26 
27  27  27  27 
28  28  28  28 
29     29  29 
30     30  30 
31     31    

 

    Online course period
Schedule for online meeting sessions, excercice deadline, and resource availability will be provided by the trainers' team

    Assessment period
Details on the exam organisation are provided by the trainers' team

FEES & SAVINGS

Application fees

The Certificate application fees amount is 25.00 Euros.

These fees can be paid either by on-line payment or by post before the application deadline. These fees are not refundable.

Tuition fees

Tuition fees for this Certificate programme depends on the appliquant's status
Students Professionals
1,500 Euros 3,000 Euros

Savings

Eu2P rewards trainees attending Eu2P Certificates by granting Eu2P points. Once accumulated, these points can be used to lower tuition fees.

Students and professionals related to Eu2P partners can also claim some saving on Certificate tuition fees.

See Eu2P tuition fee savings for further details.

SELECTION BOARD

The Eu2P Domain Board selects the Certificate trainees.

This board assesses applicants's previous education, professional experience, and prerequisites' compliance.

See Eu2P acadmic governance for further details about the Eu2P Domain Boards.

Medicines risk communication Domain Board composition
Title Partner institution Partner representative
Domain Director Université Bordeaux Segalen Paul Benkimoun
Domain Codirector Eli Lilly and Company Limited Danielle Muzard
Module Coordinator Université Bordeaux Segalen Paul Benkimoun
Module Coordinator Universita di Verona Anita Conforti


OTHER PROGRAMME REGISTRATION

This module is also included in the Master Year 2



CONTACT INFORMATION

You can contact the Eu2P central office to get further information about:

Eu2P CENTRAL OFFICE
Université Bordeaux Segalen
146 rue Léo Saignat
Case 36
33076 Bordeaux cedex
FRANCE

Send an online message to the Eu2P central office

COURSE CATALOGUE



Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners